A new trading day began on Friday, with BioAge Labs Inc (NASDAQ: BIOA) stock price up 10.57% from the previous day of trading, before settling in for the closing price of $10.5. BIOA’s price has ranged from $2.88 to $20.37 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged 65.32%. With a float of $22.50 million, this company’s outstanding shares have now reached $35.85 million.
BioAge Labs Inc (BIOA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of BioAge Labs Inc is 37.23%, while institutional ownership is 35.54%. The most recent insider transaction that took place on Dec 04 ’25, was worth 701,909. In this transaction Chief Medical Officer of this company sold 68,897 shares at a rate of $10.19, taking the stock ownership to the 0 shares. Before that another transaction happened on Dec 04 ’25, when Company’s Officer proposed sale 68,897 for $10.19, making the entire transaction worth $701,912.
BioAge Labs Inc (BIOA) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -1.75 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.65 per share during the current fiscal year.
BioAge Labs Inc (NASDAQ: BIOA) Trading Performance Indicators
Here are BioAge Labs Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 70.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.11, a number that is poised to hit -0.77 in the next quarter and is forecasted to reach -2.91 in one year’s time.
Technical Analysis of BioAge Labs Inc (BIOA)
The latest stats from [BioAge Labs Inc, BIOA] show that its last 5-days average volume of 0.5 million was superior to 0.28 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 82.78%.
During the past 100 days, BioAge Labs Inc’s (BIOA) raw stochastic average was set at 99.73%, which indicates a significant increase from 99.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.58 in the past 14 days, which was higher than the 0.32 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.27, while its 200-day Moving Average is $5.06. Now, the first resistance to watch is $12.08. This is followed by the second major resistance level at $12.55. The third major resistance level sits at $13.48. If the price goes on to break the first support level at $10.69, it is likely to go to the next support level at $9.76. Assuming the price breaks the second support level, the third support level stands at $9.29.
BioAge Labs Inc (NASDAQ: BIOA) Key Stats
With a market capitalization of 416.28 million, the company has a total of 35,855K Shares Outstanding. Currently, annual sales are 0 K while annual income is -71,110 K. The company’s previous quarter sales were 2,050 K while its latest quarter income was -20,170 K.
